{
  "id": 1070490,
  "title": "Merck EVP DeLuca sells $5.9m in stock",
  "url": "https://urgent.news/2026/08/15/merck-evp-deluca-sells-5-9m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-15T15:46:18.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/merck-evp-deluca-sells-59m-in-stock-93CH-4861806"
  },
  "original_language": "en",
  "account": "Richard DeLuca, Executive Vice President and President of Merck Animal Health, sold approximately $5.9 million worth of Merck & Co., Inc. (MRK) common stock across three days between August 10 and August 12, 2026. The executive sold a total of 45,320 shares, with transactions ranging from $130.4345 to $132.3496 per share. On August 10, DeLuca sold 20,784 shares at an average price of $130.4345, followed by two separate sales on August 11 of 7,410 and 5,427 shares at average prices of $131.3313 and $132.3496, respectively. Finally, on August 12, he sold 11,099 shares at an average price of $131.6128, along with a smaller transaction of 600 shares at an average price of $132.0367. Today, DeLuca directly owns 110,167.07 shares of Merck & Co., Inc. common stock. In recent news, Merck reported second-quarter 2026 earnings that surpassed market expectations, with revenue reaching $16.6 billion, exceeding the forecast of $16.41 billion. The company's performance was driven by strong sales in oncology, vaccines, and newer products, resulting in Merck raising and narrowing its full-year outlook.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Sysco EVP Ronald Phillips sells $558k in company stock",
        "url": "https://urgent.news/2026/08/15/sysco-evp-ronald-phillips-sells-558k-in-company-stock",
        "published": "2026-08-15T14:16:20.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}